Form D — BirchBioMed Inc.
0001670747-25-000003 · filed Jul 11, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $3,000,000
- Reported amount sold
- $175,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- BirchBioMed Inc.
- CIK
- 1670747
- Entity
- Corporation
- Jurisdiction
- BRITISH COLUMBIA, CANADA
- Year incorporated
- —
- Address
- 130 KINGSCROSS DRIVE
KING CITY, Ontario, Canada L7B 1E6 - Phone
- 905-833-3414
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mark Miller · Executive OfficerKing City, Ontario, Canada Find on LinkedIn ↗
-
John Verbeck · Executive OfficerKing City, Ontario, Canada Find on LinkedIn ↗
-
Susan Elliott · Executive OfficerKing City, Ontario, Canada Find on LinkedIn ↗
-
Carlos Camozzi · Executive OfficerKing City, Ontario, Canada Find on LinkedIn ↗
-
Teresa Bair · DirectorKing City, Ontario, Canada Find on LinkedIn ↗
-
Charles Ellis · DirectorKing City, Ontario, Canada Find on LinkedIn ↗
-
Joseph Sardano · DirectorKing City, Ontario, Canada Find on LinkedIn ↗
-
Herve Girsault · Executive OfficerKing City, Ontario, Canada Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗